Christopher Michael Cashman, CEO at MARINUS PHARMACEUTICALS INC (MRNS), sold 19,132 shares at $6.28 ($120K) on 2018-01-18, disclosed to the SEC on 2018-01-22.
Open-market sale of $120k MRNS by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.28 | 9,566 | $60K | 50.0% |
| 2 | $6.28 | 9,566 | $60K | 50.0% |
| Total | $6.28 avg | 19,132 | $120K | 100% |
| Filing → |